November 29, 2016 – Canadian Cancer Survivor Network partners with CanniMed Ltd. for medical cannabis education

 Medical cannabis is increasingly becoming an option considered by patients to help manage symptoms related to current or past cancer treatment. But when patients weigh the pros and cons of including this therapeutic option, a multitude of questions abound.

What are the rules and regulations around cannabis in Canada? How do patients gain access to this treatment option? What are the dosing options? Is it a treatment option for chemotherapy-induced nausea? What about cancer-induced neuropathic pain?

These, and countless others, are the questions we hear every day. This is why we are proud to announce our partnership with CanniMed Ltd., one of Canada’s leading licensed producers of medical cannabis. CanniMed’s dedication to helping their patients find relief is grounded in an industry-leading focus on the production of pharmaceutical-grade cannabis following Good Manufacturing Practices – the same strict requirements placed on all pharmaceutical companies. This ensures that patients can trust their medicine every time.

We are looking forward to the ongoing collaboration with CanniMed to provide our membership with valuable resources and credible education that will help them make informed decisions about the use of medical cannabis.

Available now on our website (http://survivornet.ca/en/cancer_basics/medical_cannabis/) you will see four new resource documents that provide the starting point for information regarding medical cannabis. In them you will find the answers to the most common questions, such as what is medical cannabis, how do you go about getting a prescription, the best ways to ingest it and a sheet devoted to the myths and facts of what can be a stigmatized treatment option.

On Monday, December 12th, we will be hosting the latest in our webinar series on the topic. We are thrilled to be joined by Dr. Paul Daeninck, an oncologist and palliative care consultant with CancerCare Manitoba and an Assistant Professor at the University of Manitoba. Dr. Daeninck is one of Canada’s leading physicians when it comes to the use of cannabis in patients with cancer and cancer-related conditions. This webinar is a must-watch to learn about the basic facts about medical cannabis and the role it can play for cancer patients. Don’t miss this informative free webinar, registration will be posted here.

The medical cannabis landscape in Canada is changing rapidly and it is our commitment to ensure that each of you remain current on the topic and how it affects you. This includes news on the most recent clinical research, new governmental policies that will be enacted – including the pending legalization for recreational use – and advocacy initiatives that we are involved with.

Our partnership with CanniMed ensures that we can continue to fulfill that commitment to you, now and into the future.